Is gemtuzumab/gemtuzumab (MYLOTARG) a targeted drug?
Gemtuzumab/Gemtuzumab (MYLOTARG) is a targeted therapy drug mainly used to treat acute myeloid leukemia (AML), which is a malignant bone marrow disease. Targeted therapy is a method of precisely attacking cancer cells by specifically interfering with their survival, growth and spread mechanisms without causing widespread damage to normal cells. Gemtuzumab/Gemtuzumab plays a key role in this regard.
Gemtuzumab/Gemtuzumab achieves highly specific targeting by binding to the CD33 antigen on the surface of leukemia cells. CD33 is a protein that is overexpressed on the surface of AML cells, while normal bone marrow cells usually express less or no CD33. This allows Gemtuzumab to selectively target and recognize AML cells without affecting healthy bone marrow cells.

Once gemtuzumab/gemtuzumab binds to CD33antigen, it activates the host immune system, including natural killer cells (NK cells) and macrophages. These immune cells will be activated, coaxing them to attack and destroy CD33-positive AML cells. This involvement of the immune system enhances the effectiveness of the treatment because it uses the body's own defense mechanisms to fight cancer cells.
Due to the specific effect of Gemtuzumab/Gemtuzumab, it can reduce some side effects compared with traditional chemotherapy drugs because it will not cause extensive damage to normal cells. This means patients typically experience fewer toxic side effects during treatment, improving treatment tolerability.
Gemtuzumab/GemtuzumabIt is not currently on the market in China, so it cannot be included in medical insurance. Patients cannot purchase it domestically and need to purchase it through overseas channelsGemtuzumab/Gemtuzumab. Foreign Gemtuzumab/Gemtuzumab is only Pfizer’s original drug, which is expensive, and the cheaper ones are mainly Turkish original drugs. The price of the drug is around 45,000 yuan, and the price of the original drug in Hong Kong, China is around 65,000 yuan, and the ingredients and efficacy of the original drug are consistent.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)